InvestorsHub Logo
Followers 4
Posts 75
Boards Moderated 1
Alias Born 08/05/2013

Re: None

Thursday, 12/26/2013 4:26:24 PM

Thursday, December 26, 2013 4:26:24 PM

Post# of 345981
todays dallas business journal-

The same class of drug used in the experiments is being evaluated in phase 1 and 2 trials for treatment of leukemia and a subtype of lung cancer, Le said. Meanwhile, UT Southwestern is working with a pharmaceutical company to develop a similar BRD4-inhibiting drug to launch a clinical trial for MPNST patients.

http://www.bizjournals.com/dallas/blog/2013/12/ut-southwestern-study-identifies.html?ana=e_du_pub&s=article_du&ed=2013-12-26&page=2
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News